(±) 13 (14) -EpDPA

(±) 13 (14) -EpDPA (13,14-EpDPE) is the product of the reaction of cytochrome P-450 epoxygenase with Docosahexaenoic Acid (DHA) . (±) 13 (14) -EpDPA has antihyperalgesic and vasorelaxative activities[1].

Product Specifications

CAS Number

[895127-64-7]

Product Name Alternative

13,14-EpDPE

UNSPSC

12352005

Target

Cytochrome P450

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Neurological Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/racemic-13-14-epdpa.html

Concentration

290.28 μM * 250 μL in Ethanol

Purity

95.0

Smiles

O=C(O)CC/C=C\C/C=C\C/C=C\CC1OC1C/C=C\C/C=C\CC

Molecular Formula

C22H32O3

Molecular Weight

344.49

References & Citations

[1]Christophe Morisseau, et al. Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids. J Lipid Res. 2010 Dec;51 (12) :3481-90.